CGP-78608

CAS: 206648-13-7 F: C11H13BrN3O5P W: 378.12

CGP 78608 is a highly potent and selective antagonist at the glycine-binding site of the NMDA receptor, with an IC50 of

Contact QiTai

This product is for research use only, not for human use. We do not sell to patients.

Bioactivity	CGP 78608 is a highly potent and selective antagonist at the glycine-binding site of the NMDA receptor, with an IC50 of 6 nM. CGP 78608 acts as a potentiator of GluN1/GluN3A-mediated glycine currents, with an estimated EC50 in the low nM range (26.3 nM). CGP 78608 has anticonvulsant activities[1][2].
Invitro	CGP-78608 通过 GluN1 和 GluN3A 激动剂结合域 (ABD) 位点之间的亚基间变构效应降低 GluN1/GluN3A 受体的甘氨酸敏感性[2]。CGP 78608 减少或消除氨依赖性 cGMP 合成，这是氨神经毒性的致病因素[3]。 MCE has not independently confirmed the accuracy of these methods. They are for reference only. 0 --> CGP-78608 相关抗体:
In Vivo	CGP-78608 在小鼠电击诱发的惊厥试验中腹腔注射后表现出强效的抗惊厥作用[1]。 MCE has not independently confirmed the accuracy of these methods. They are for reference only.
CAS	206648-13-7
Formula	C11H13BrN3O5P
Molar Mass	378.12
Transport	Room temperature in continental US; may vary elsewhere.
Storage	Please store the product under the recommended conditions in the Certificate of Analysis.
Reference	[1]. Catarzi D, et al. Competitive Gly/NMDA receptor antagonists. Curr Top Med Chem. 2006;6(8):809-21. [2]. Grand T, et al. Unmasking GluN1/GluN3A excitatory glycine NMDA receptors. Nat Commun. 2018 Nov 13;9(1):4769. [3]. Hilgier W, et al. A novel glycine site-specific N-methyl-D-aspartate receptor antagonist prevents activation of the NMDA/NO/CGMP pathway by ammonia. Brain Res. 2004 Jul 23;1015(1-2):186-8.

(E)-Broparestrol